Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Johnson & Johnson (NY: JNJ )

151.04 +6.45 (+4.46%)
Streaming Delayed Price Updated: 11:28 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Johnson & Johnson

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Asia Summit on Global Health gathers 90+ global elites
From HKTDC
Via ACN Newswire
Is Novavax Finally Turning Things Around?
Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea 
Via MarketBeat
Exposures COVID-19
UnitedHealth Group is an AI Stock That Isn't Beating Expectations
Although it's a pioneer in AI, UnitedHealth Group is not enjoying the halo effect on AI stocks, but with more clarity on future growth that should change 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Recession-Proof Stocks With Nice Dividends
Certain sectors like consumer staples and health care tend to outperform during economic turbulence. These three stocks are good names to own for the bad times. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Attorney Paul Dagostino Joins Bisnar Chase's Personal Injury Litigation Team
Newport Beach personal injury law firm Bisnar Chase recently welcomed Paul Dagostino to its litigation team. Dagostino's practice focuses on mass tort, class action and product liability cases. He was... 
Via PRLog
Johnson & Johnson (NYSE: JNJ) Making Surprising Moves in Wednesday Session
Via Investor Brand Network
Johnson & Johnson (NYSE: JNJ) is Today’s Stock Spotlight
Via Investor Brand Network
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
J&J Kenvue Spinoff Aims To Give Investors A Healthy Return
Johnson & Johnson spinoff Kenvue had the biggest IPO since 2021, raising $3.8 billion. Kenvue's brands include Band-Aid, Tylenol, Neutrogena and Listerine. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Regeneron Beats Q1 Views, But Stock Drops On Weak Eye Med Sales
Regeneron reported better-than-expected Q1 earnings and revenue, but its Eylea sales fell, losing ground to Roche's newly launched Vabysmo. 
Via MarketBeat
International Healthcare Week returns to showcase Hong Kong's strengths in healthcare innovation and investment
From HKTDC
Via ACN Newswire
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
From Johnson & Johnson
Via Business Wire
Discover the Best Stocks to Invest In During a Recession
In times of economic uncertainty, such as during a recession, it can be challenging to know where to invest your 
Via Spotlight Growth
Topics Economy
Exposures Economy
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
6 Best Healthcare Stocks to Buy Right Now
Whether you invest in healthcare stocks for pharmaceuticals, medical devices or health insurance, the opportunities are limitless. Learn more with MarketBeat. 
Via MarketBeat
Topics Economy Intellectual Property
Exposures Economy Intellectual Property Product Safety
Why Legend Biotech Stock Is Having Its Best Month Yet
With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high. 
Via MarketBeat
Johnson & Johnson Announces Launch of Kenvue Inc. IPO Roadshow
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Earnings Mix Some Good with Some Concerns
Shares of Johnson & Johnson are down as investors digest an earnings report that delivered some good news and some concerns for investors 
Via MarketBeat
Topics Economy
Exposures Economy
Chadd Johnson Joins NFM Influencer Division as Branch Manager
Linthicum, Maryland () April 19, 2023 -- There is a sense that we are on the forefront of changing this industry for the better, and it’s exciting to be part of it. I can’t wait to see what the future... 
Via Prodigy
Johnson & Johnson Reports Q1 2023 Results
From Johnson & Johnson
Via Business Wire
MarketBeat Week in Review – 4/10 - 4/14
The market continues to seek direction, but the MarketBeat analysts are helping you find opportunities. Here are some of this week's most popular articles. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Why Next Week's Earnings Report is Good for Johnson & Johnson
Investors have had to digest some negative news headlines, but if you look past that a dividend king like JNJ can be a boring but reliable buy in this market 
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
Epic Growth Story Predicted for Pharmaceutical Drug Delivery Market's Future: Johnson & Johnson, Novartis International, Merck
Stay up-to-date with Pharmaceutical Drug Delivery Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
From Johnson & Johnson
Via Business Wire
Baby Health and Personal Care Market May See a Big Move : Johnson & Johnson, Danone, Pigeon
NJ New Jersey, USA -- (SBWIRE) -- 03/28/2023 -- Advance Market Analytics published a new research publication on "Baby Health and Personal Care Market Insights, to 2028" with 232 pages and enriched... 
Via SBWire
Exposures Textiles
New Regional Director for EMEA to Drive Next Stage of Growth Across the Region for Jeron Nurse Call Systems
NILES, Ill. - March 24, 2023 - PRLog -- Jeron Electronic Systems, Inc. announced today that Dr. Ahmed Adel MBA-MDS has joined the Jeron sales team as the Regional Director for the EMEA. In this newly... 
Via PRLog
Topics Economy
Exposures Supply Chain
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
By Julian Richard, Benzinga 
Via TheNewswire.com
Exposures Product Safety
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.